On October 13, 2026, Ponce Medical and South Korean MetaLabs held a cooperation signing ceremony at Ponce Medical's Shanghai office. Zhang Zhaodong, CEO of Ponce Medical, He Yundi, VP of Ponce Medical Products, as well as He Zhicheng, CEO of MetaLabs, Jin Xiuxian, CEO of MetaRobotics, and Cui Yong, Dean of Hair Transplantation, attended the event together. The two sides signed a cooperation agreement and exchanged views on in-depth cooperation for the Korean hair market. This is a step forward in the global layout of Ponce Medical, and also a two-way journey between the "Chinese original AI hair transplant robot" and the "mature hair medical market in South Korea".

Pang Ce Medical CEO Zhang Zhaodong and MetaLabs representative director He Zhicheng sign contract

Signing the contract immediately, China and South Korea jointly embark on a new era of intelligent hair medical technology

At the ceremony, representatives from both sides signed the agreement, exchanged texts, and took a group photo as a souvenir. From guest reception to formal signing, and then to group photos and product visits, a simple yet solemn ceremony was built upon months of communication and mutual trust between both parties.

This signing marks the official establishment of a partnership between Ponce Medical and MetaLabs. Both parties will collaborate on the application exploration of HAIRO hair transplant robots, clinical collaboration among hair transplant institutions, and exchange and linkage between products and academia in the Korean market, to jointly promote the standardized implementation of AI hair transplantation in the Korean context.

MetaLabs team visits Ponce Medical

Joining hands with South Korean MetaLabs: Seeking answers from highly mature markets

South Korea is one of the highly mature markets in the global hair medical and aesthetic industries. A complete system has been formed for hair transplantation, postoperative care, scalp management, and refined services. Institutions also have leading requirements for surgical efficiency, standardization capabilities, and patient experience in the industry. This level of maturity is the soil for AI hair transplant robots to unleash their value: when doctors are liberated from high-intensity and repetitive manual operations, institutions are expected to gain new room for improvement in surgical consistency and service efficiency.

The market size is also considerable. Taking MomoLabs, a subsidiary of MetaLabs, as an example, the total number of hair transplant consultations disclosed on the official websites of its branches in 2025 is about 130000, and the number of hair transplant surgeries is about 40000; In terms of cooperative networks, MomoLabs has disclosed to the public that it has about 24 cooperative hospitals and generates approximately 100000 patient data records annually. MetaLabs Plastic Surgery, as one of the representative institutions in the field of hair healthcare in Korea, has rich experience in fine hair transplantation and one-stop hair health management.

Pang Ce Medical chose South Korea not only for its market size, but also for its acceptance of technological innovation and industrialization capabilities. Taking the real demand for standardization and efficiency in mature markets as the driving force, and making technology truly serve clinical practice, this is the underlying logic of this cooperation.

Hardcore technology is the passport to going abroad

The HAIRO hair transplant robot, independently developed, supports the entry of Ponce Medical into the Korean market. As the first domestically produced hair transplant robot approved for market in Asia, HAIRO's breakthrough lies in the millimeter or even micrometer range: the self-developed 0.8mm minimally invasive needle works in conjunction with a patented tensioner to control hair retrieval accuracy at 0.01mm and depth control accuracy at 0.05mm. While protecting hair follicle viability as much as possible, it achieves an extraction efficiency of about 2700Fu/H per hour, with an automatic hair follicle extraction accuracy of about 95%.

More noteworthy is its' thinking ability '. The intelligent extraction system equipped by HAIRO can dynamically optimize the extraction scheme based on the patient's hair characteristics, making standardization no longer uniform, but precise delivery that varies from person to person. At the signing site, HAIRO demonstrated the smooth and stable operation of hair follicle extraction and multi embryo priority extraction, visually demonstrating the leading technological maturity and attracting the attention and recognition of the MetaLabs team.

From Shanghai to Seoul: Globalization is Steady and Steady

From deep cooperation with top domestic medical institutions to continuous expansion into overseas markets such as Southeast Asia and South Korea, the globalization of Ponce Medical is not achieved overnight, but gradually promoted along the path of technology validation, clinical collaboration, channel co construction, and brand synergy. The collaboration with MetaLabs is another solid landing point on this path. It means that Ponce Medical's AI hair transplant solution is being seen, recognized, and introduced by more and more international professional markets.

AI is reshaping the way healthcare services are delivered, and hair care is at the forefront of intelligent transformation. HAIRO's continuous breakthroughs in precision, efficiency, and intelligence signify that China is moving towards becoming a "global innovation leader" in the field of intelligent hair surgery. This cross-border handshake is not only about Ponce Medical entering an overseas new market, but also a powerful proof of China's original medical robots entering the international professional stage and participating in reshaping the global hair medical landscape with hardcore technology. In the future, Ponce Medical will continue to anchor clinical value and respond to global hair health needs with smarter, more accurate, and safer solutions, showcasing the power of Chinese AI healthcare to the world.